Please assess the completion status of the following clinical trial:

Trial Title: Treatment Outcomes for Temporomandibular Disorders (TMD) Via the Clayton Intra-aural Device (CID) Clinical Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~A subject must meet all of the following criteria to be eligible for study participation:~* Subjects who present to IMIC for jaw pain or dysfunction~* Subjects who sign and date an IRB/EC approved informed consent form~* Subjects must have an RDC/TMD diagnoses that include at least one of the following:~  * Myofascial Pain~ * Arthralgia~ * Disc displacement with reduction; AND~The subject has the presence of one or more of the following findings associated with pain as demonstrated with a VAS score of \>4:~* Increased (\>60mm) or decreased (\<40mm) range of interincisal jaw opening;~* Pain upon any jaw movement;~* Pain on digital palpation (about 0.45 kg of pressure) of the periauricular area or external auditory meatal areas;~* Pain on digital palpation (about 0.45 kg of pressure) in 2 or more muscles of mastication; or~* Joint sound with pain~Exclusion Criteria:~* Subjects diagnosed with rheumatoid arthritis, osteoarthritis, osteoarthrosis or another connective tissue disorder~* Subjects who have had direct trauma to the jaw~* Subjects who have used an occlusal appliance to treat a TMD within the previous six months~* Subjects who have had prior TMJ or ear surgery~* Subjects with any physical or behavioral disorder, which, in the opinion of the Principal Investigator, may interfere with the use of the device or compliance with the study protocol~* Subjects who have a narrow ear canal or impression of the ear canal, which is prolapsed due to an anatomical shift or failure of the ear canal wall structure, or a canal that does not allow for the ear canal second turn to be identified~* Subjects with visible or congenital ear deformity as observed on targeted physical exam~* Subjects whose ear canal anatomy does not allow for fit of the study device~* Subjects who have taken a narcotic pain medication in the last seven days or who have taken aspirin or a non-steroidal anti-inflammatory agent in the last 24 hours~* Subjects who have a history of ear pain unrelated to TMJ~* Subjects who have a history of ear drainage in the past 2 years~* Subjects who have active ear drainage, swelling, or redness as observed on targeted physical exam~* Subjects whom the investigator believes may not be a appropriate candidates for an intra-oral splint due to missing or poor quality dentition or untreated pain of dental origin (pulpal pain, pericoronitis of wisdom teeth, or similar conditions)

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Treatment group receiving the CID
- 2 (Type: ACTIVE_COMPARATOR): Group assigned a mouth splint
- Exercise Control Group (Type: ACTIVE_COMPARATOR): Group who received no device but were instead assigned a study-specified jaw exercise program

Based on this trial design, predict the completion outcome and termination type (if applicable).